Calmare Scrambler Research
For providers and interested patients, this is a list of citations for the currently published research literature on Calmare Scrambler Therapy, underscoring its validated efficacy in the modulation of neuropathic pain. These studies offer profound insights into the mechanistic action of Calmare Scrambler Therapy in managing intractable pain and improving functional outcomes for individuals with conditions such as peripheral neuropathy and fibromyalgia.
Delve into our comprehensive repository of Calmare Scrambler Therapy research to gain a deeper understanding.
Reference & Overview Articles (Start Here)
Cutaneous Electroanalgesia for Relief of Chronic and Neuropathic Pain
Smith TJ, Wang EJ, Loprinzi CL. N Engl J Med. 2023 Jul 13;389(2):158-164. doi: 10.1056/NEJMra2110098.
Key Takeaway: A landmark Johns Hopkins/Mayo Clinic review published in the world's top medical journal, validating Scrambler Therapy as a highly effective, non-invasive alternative that can provide substantial relief to 80–90% of chronic pain patients.
Inside the Scrambler Therapy, a Noninvasive Treatment of Chronic Neuropathic and Cancer Pain
Marineo G. Integr Cancer Ther. 2019 Jan-Dec;18:1534735419845143. doi: 10.1177/1534735419845143.
Key Takeaway: Written by the inventor of the therapy, this paper explains the biophysics of how the device actively replaces "pain" information with "non-pain" information at the central nervous system level.
Untreatable pain resulting from abdominal cancer: new hope from biophysics?
Marineo G. JOP. 2003 Jan;4(1):1-10. PMID: 12555009.
Key Takeaway: The foundational early paper introducing the concept of using synthetic neuro-electric signals to manage severe, drug-resistant cancer pain.
​
Systematic Reviews & Meta-Analyses
Efficacy of scrambler therapy in chronic neuropathic pain: pairwise and dose-response meta-analysis
Brain Netw Modul. 2024 Jul-Sep;3(3):63–70. doi: 10.4103/bnm.bnm_20_24.
​
Key Takeaway: A recent meta-analysis confirming the dose-response efficacy of the therapy, showing how multiple sequential sessions compound to create longer-lasting neuropathic pain relief.
The Use of Scrambler Therapy in Treating Chronic Pain Syndromes: A Systematic Review
Karri J, Marathe A, Smith TJ, Wang EJ. Neuromodulation. 2022 Jun 9:S1094-7159(22)00681-X. doi: 10.1016/j.neurom.2022.04.045.
Key Takeaway: Concludes that Scrambler Therapy is highly safe, well-tolerated, and yields clinically meaningful pain reduction, particularly for chemotherapy-induced neuropathy.
Safety of Scrambler Therapy: A Systematic Review of Complications and Adverse Effects
Wang EJ, et al. Pain Med. 2022 Sep 7:pnac137. doi: 10.1093/pm/pnac137.
Key Takeaway: A comprehensive safety review confirming that adverse effects are extremely rare and typically limited to minor, temporary skin irritation at the electrode site.
Scrambler therapy: An opioid-sparing, non-invasive modality for chronic pain in patients
Nair A. Saudi J Anaesth. 2022 Oct-Dec;16(4):525-526. doi: 10.4103/sja.sja_366_22.
Key Takeaway: Highlights the critical role of the therapy in reducing patient reliance on opioid medications for chronic pain management.
Painful Diabetic Neuropathy - A Narrative Review
Wang EJ, Berninger LE, Komargodski O, Smith TJ. Pain Physician. 2022 Nov;25(8):E1163-E1173.
Key Takeaway: Compares Scrambler Therapy favorably against spinal cord stimulation and TENS for treating painful diabetic nerve damage.
Scrambler therapy for noncancer neuropathic pain: a focused review
Abdi S, Chung M, Marineo G. Curr Opin Anaesthesiol. 2021 Dec 1;34(6):768-773.
Key Takeaway: Expands the evidence base beyond cancer, showing strong efficacy for general non-cancer neuropathic pain conditions.
Scrambler Therapy for the management of chronic pain
Majithia N, et al. Support Care Cancer. 2016 Jun;24(6):2807-14.
Key Takeaway: An earlier Mayo Clinic review establishing the device as a promising modality for difficult-to-treat chronic pain conditions.
​
Randomized Controlled Trials
Scrambler Therapy: a safe and effective way to treat chemo-induced neuropathy [Abstract]
Wang Z, Loprinzi CL, Abdi S, Strouse TB, Smith TJ. Clin Cancer Res. 2026 Feb;32(4 Suppl):PS1-02-17.
Key Takeaway: A 2026 review of multiple institutional trials (Hopkins, Mayo, MD Anderson) confirming up to a 60% reduction in pain for chemo-induced neuropathy, with some patients achieving complete remission.
Efficacy of Scrambler Therapy in Veterans With Neuropathic Pain: A Multicenter Prospective Study
DeSantana JM, da Silva JT, Sluka KA. Military Medicine. 2024; 189(1): 33–40.
Key Takeaway: A multi-site VA trial demonstrating significant pain reduction and sleep improvement in veterans suffering from postherpetic neuralgia and traumatic neuropathies.
Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial
Coyne PJ, Wan W, Swainey C, Wainer J. Journal of Pain Research. 2023; 16: 221–229.
Key Takeaway: An NIH-supported trial showing that over 70% of participants experienced greater than a 50% reduction in nerve pain lasting up to 3 months.
Scrambler Therapy Enhances Quality of Life in Cancer Patients in a Palliative Care Setting
Kashyap K, et al. Indian J Palliat Care. 2022 Jul-Sep;28(3):287-294.
Key Takeaway: Demonstrates that by significantly reducing pain, the therapy also creates measurable improvements in the overall quality of life for palliative cancer patients.
Scrambler Therapy for Chronic Pain after Burns and Its Effect on the Cerebral Pain Network
Lee SY, et al. J Clin Med. 2022 Jul 22;11(15):4255.
Key Takeaway: Proves the therapy is effective for severe burn-related pain and uses brain imaging to show how it positively alters the brain's pain network.
Randomized Trial of Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy: Crossover Analysis
Childs DS, et al. J Pain Symptom Manage. 2021 Jun;61(6):1247-1253.
Key Takeaway: A crossover trial showing that patients who failed to get relief from a standard TENS unit experienced significant relief when switched to Scrambler Therapy.
The Efficacy of Scrambler Therapy for the Management of Head, Neck and Thoracic Cancer Pain
Kashyap K, et al. Pain Physician. 2020 Sep;23(5):495-506.
Key Takeaway: Validates the device's efficacy in managing the highly complex pain profiles associated with upper-body cancers.
Scrambler therapy improves pain in neuromyelitis optica
Mealy MA, et al. Neurology. 2020 May 5;94(18):e1900-e1907.
Key Takeaway: Shows success in treating central neuropathic pain caused by autoimmune central nervous system disorders.
Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial
Loprinzi C, et al. Support Care Cancer. 2020 Mar;28(3):1183-1197.
Key Takeaway: A direct head-to-head Mayo Clinic trial where Scrambler Therapy vastly outperformed standard TENS units for chemotherapy nerve pain.
Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management
Marineo G, et al. J Pain Symptom Manage. 2012 Jan;43(1):87-95.
Key Takeaway: A pivotal early trial demonstrating that the device provided better pain relief than standard, guideline-based prescription drug treatments.
​
Observational Studies & Clinical Trials
Refractory chronic neuropathic pain successfully treated with scrambler therapy
Sadik E, et al. Prim Care Companion CNS Disord. 2026 May 26;28(3):25cr04084.
Key Takeaway: Recent 2026 clinical data highlighting the treatment's success in patients who had previously failed all other standard medical interventions.
Fellows research article: use of scrambler therapy to treat small fiber neuropathy
Sanchez KT, Smith TJ. Pain Medicine. 2024 Feb; 25(2): 157–159.
Key Takeaway: Demonstrates targeted success in treating small fiber neuropathy, a notoriously difficult-to-treat form of nerve damage.
Scrambler therapy: what's new after 15 years? The results from 219 patients
Ricci M, et al. Medicine (Baltimore). 2019 Jan;98(2):e13895.
Key Takeaway: A massive long-term data review of 219 patients confirming the therapy's lasting efficacy and safety over a decade and a half of clinical use.
Scrambler therapy efficacy and safety for neuropathic pain correlated with chemotherapy-induced peripheral neuropathy in adolescents
Tomasello C, et al. Pediatr Blood Cancer. 2018 Jul;65(7):e27064.
Key Takeaway: Proves the therapy is gentle and safe enough to successfully treat severe nerve pain in pediatric/adolescent
cancer patients.
Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy
Pachman DR, et al. Support Care Cancer. 2015 Apr;23(4):943-51.
Key Takeaway: An early Mayo Clinic study showing a 53% reduction in pain, alongside significant reductions in tingling and numbness.
Chronic pain treatment and scrambler therapy: a multicenter retrospective analysis
Compagnone C, Tagliaferri F. Acta Biomed. 2015 Sep 14;86(2):149-56.
Key Takeaway: Multi-hospital data confirming the real-world effectiveness of the therapy outside of tightly controlled clinical trial environments.
Treatment of Postherpetic Pain With Scrambler Therapy
Smith TJ, Marineo G. Am J Hosp Palliat Care. 2018 May;35(5):812-813.
Key Takeaway: Shows the device is highly effective at treating the agonizing, lingering nerve pain caused by Shingles (postherpetic neuralgia).
Additional observational trials by Notaro [2016], Coyne [2013], Kashyap [2017], Lee [2016], Ko [2013], Ghatak [2011], Sabato [2005]: These universally echo the same findings—validating efficacy in visceral metastasis, complex low back pain, and postherpetic neuralgia across various global pilot studies.
​
Notable Case Reports
Scrambler Therapy for Patients With Complex Regional Pain Syndrome: A Case Series
Wang AT, et al. J Palliat Med. 2023 Sep;26(9):1302-1306.
Key Takeaway: Proves that the therapy can calm the severe, localized burning pain associated with CRPS.
Scrambler Therapy for the Treatment of Pain in Schwannomatosis
Murphy T, Erdek M, Smith TJ. Cureus. 2022 Mar 13;14(3):e23124.
Key Takeaway: Highlights relief for patients with painful nerve sheath tumors.
Treatment of Déjerine-Roussy syndrome pain with scrambler therapy
Christo PJ, Kamson DO, Smith TJ. Pain Manag. 2020 May;10(3):141-145.
Key Takeaway: Shows successful intervention for "central pain syndrome," a severe condition caused by stroke damage to the brain's thalamus.
Phantom limb pain successfully treated with scrambler therapy
Fabbri L, et al. Minerva Anestesiol. 2018 May;84(5):642-643.
Key Takeaway: Demonstrates how the therapy can rewire the brain to stop perceiving pain in limbs that have been amputated.
Treatment of human immunodeficiency virus-related peripheral neuropathy with Scrambler Therapy
Smith TJ, et al. Int J STD AIDS. 2017 Feb;28(2):202-204.
Key Takeaway: Shows success in treating the specific, painful peripheral nerve damage often caused by HIV and its treatments.
CRPS Resources:
​
This is a treasure trove of information for patients dealing with CRPS/RSD. This links directly to their comprehensive "information packages" for Adults and Children that every patient should have.
​
Burning Nights CRPS Support
This is another organization committed to sharing resources, knowledge, and support for CRPS warriors around the globe.